2 min

Firstline pembrolizumab for metastatic urothelial cancer ESMO 2016

    • Medicine

Dr Balar speaks with ecancertv at ESMO 2016 about the outcomes of patients receiving immune checkpoint therapy as a first line treatment against metastatic urothelial cancer.

Dr Balar speaks with ecancertv at ESMO 2016 about the outcomes of patients receiving immune checkpoint therapy as a first line treatment against metastatic urothelial cancer.

2 min

Top Podcasts In Medicine

More by ecancer